Skip to Main Content

Paper Details

Moving Toward Personalized Care: Liquid Biopsy Predicts Response to Cisplatin in an Unusual Case of BRCA2-Null Neuroendocrine Prostate Cancer.
Clin Genitourin Cancer
15
2016
Author NameAffiliation
Matti AnnalaUniversity of British Columbia, Canada Institute of Biosciences and Medical Technology
Martin E GleaveUniversity of British Columbia
Kim N ChiUniversity of British Columbia
Alexander W WyattUniversity of British Columbia
  • 1 - 4

Datasets

Release 1.2